Treatment progression in sulfonylurea and dipeptidyl peptidase-4 inhibitor cohorts of type 2 diabetes patients on metformin

Xiaomei PengEli Lilly and Company, Global Patient Outcomes and Real World Evidence, Indianapolis, IN, USACorrespondence[email protected]

Dingfeng JiangEli Lilly and Company, Global Patient Outcomes and Real World Evidence, Indianapolis, IN, USA

Dongju LiuEli Lilly and Company, Global Patient Outcomes and Real World Evidence, Indianapolis, IN, USA

Oralee J VarnadoEli Lilly and Company, Global Patient Outcomes and Real World Evidence, Indianapolis, IN, USA

Jay P BaeEli Lilly and Company, Global Patient Outcomes and Real World Evidence, Indianapolis, IN, USA

Pages 1539-1546 | Published online: 10 Aug 2016

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

InzucchiSEBergenstalRMBuseJBManagement of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)Diabetes Care20123561364137922517736
PubMed Web of Science ®Google Scholar
InzucchiSEBergenstalRMBuseJBManagement of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of DiabetesDiabetes Care201538114014925538310
PubMed Web of Science ®Google Scholar
BaileyCJTurnerRCMetforminN Engl J Med199633495745798569826
PubMed Web of Science ®Google Scholar
LamannaCMonamiMMarchionniNMannucciEEffect of metformin on cardiovascular events and mortality: a meta-analysis of randomized clinical trialsDiabetes Obes Metab201113322122821205121
PubMed Web of Science ®Google Scholar
DeziiCMKawabataHTranMEffects of once-daily and twice-daily dosing on adherence with prescribed glipizide oral therapy for type 2 diabetesSouth Med J2002951687111827247
PubMed Web of Science ®Google Scholar
IngersollKSCohenJThe impact of medication regimen factors on adherence to chronic treatment: a review of literatureJ Behav Med200831321322418202907
PubMed Web of Science ®Google Scholar
MelikianCWhiteTJVanderplasADeziiCMChangEAdherence to oral antidiabetic therapy in a managed care organization: a comparison of monotherapy, combination therapy, and fixed-dose combination therapyClin Ther200224346046711952029
PubMed Web of Science ®Google Scholar
RubinRRAdherence to pharmacologic therapy in patients with type 2 diabetes mellitusAm J Med2005118suppl 5A27S34S15850551
PubMed Web of Science ®Google Scholar
ZhangLZakharyanAStocklKMHaradaASCurtisBSSolowBKMail-order pharmacy use and medication adherence among medicare Part D beneficiaries with diabetesJ Med Econ201114556256721728913
PubMedGoogle Scholar
FarrAMSheehanJJCurkendallSMSmithDMJohnstonSSKalsekarIRetrospective analysis of long-term adherence to and persistence with DPP-4 inhibitors in US adults with type 2 diabetes mellitusAdv Ther201431121287130525504156
PubMed Web of Science ®Google Scholar
RathmannWKostevKGruenbergerJBDworakMBaderGGianiGTreatment persistence, hypoglycaemia and clinical outcomes in type 2 diabetes patients with dipeptidyl peptidase-4 inhibitors and sulphonylureas: a primary care database analysisDiabetes Obes Metab2013151556122862879
PubMed Web of Science ®Google Scholar
KarveSClevesMAHelmMHudsonTJWestDSMartinBCGood and poor adherence: optimal cut-point for adherence measures using administrative claims dataCurr Med Res Opin20092592303231019635045
PubMed Web of Science ®Google Scholar
D’AgostinoRBJrPropensity score methods for bias reduction in the comparison of a treatment to a non-randomized control groupStat Med19981719226522819802183
PubMed Web of Science ®Google Scholar
DruckerDJNauckMAThe incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetesLancet200636895481696170517098089
PubMed Web of Science ®Google Scholar
MishrikyBMCummingsDMTanenbergRJThe efficacy and safety of DPP4 inhibitors compared to sulfonylureas as add-on therapy to metformin in patients with Type 2 diabetes: a systematic review and meta-analysisDiabetes Res Clin Pract2015109237838826059071
PubMed Web of Science ®Google Scholar
DoggrellSAWarotSThe association between the measurement of adherence to anti-diabetes medicine and the HbA1cInt J Clin Pharm201436348849724710953
PubMed Web of Science ®Google Scholar
NauDPRecommendations for improving adherence to type 2 diabetes mellitus therapy – focus on optimizing oral and non-insulin therapiesAm J Manag Care2012183 supplS49S5422558942
PubMedGoogle Scholar
RascatiKLRichardsKMLopezDChengLIWilsonJPProgression to insulin for patients with diabetes mellitus using the Texas Medicaid databaseClin Ther201133122016202022101160
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Treatment progression in sulfonylurea and dipeptidyl peptidase-4 inhibitor cohorts of type 2 diabetes patients on metformin

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Treatment progression in sulfonylurea and dipeptidyl peptidase-4 inhibitor cohorts of type 2 diabetes patients on metformin

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date